Search Results 781-790 of 17078 for egfr

1. A Study to Evaluate Baricitinib (LY3009104) to Treat Cutaneous Lichen Planus - Mayo Clinic

   Significant renal disease including patients with estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73m^2. Active systemic infections during the 2 ...

2. 177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer - Mayo Clinic

   - eGFR ≥ 50 mL/min/1.73m2 using the Modification of Diet in Renal Disease (MDRD) equation 12. Albumin ≥ 2.5 g/dL 13. Candidates for change in ARDT as ...

3. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

   Anti-EGFR (epidermal growth factor receptor) monoclonal antibody, if eligible for this therapy. Measurable disease as defined: A non-nodal lesion is ...

4. End-stage renal disease - Doctors and departments - Mayo Clinic

   When kidneys no longer function well enough to meet a body's needs, treatment involves kidney dialysis or kidney transplant.

5. Study of BLU-667 in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors - Mayo Clinic

   For example, NSCLC with a targetable mutation in EGFR, ALK, ROS1, or BRAF; colorectal with an oncogenic KRAS, NRAS, or BRAF mutation. Investigators should ...

6. A Study to Evaluate Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery - Mayo Clinic

   Chronic kidney disease Stage 4 or 5 or an estimated Glomerular Filtration Rate (eGFR) < 30 mL/min/1.73 m2 at screening. Hepatic disease, including serum ...

7. Recurrent Cancer Clinical Trials - Mayo Clinic Research

   ... EGFR gene-amplified solid tumors. A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With ...

8. Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx - Mayo Clinic

   The purpose of this study is to evaluate 12-month kidney function in highly sensitized (cPRA ≥99.9%) kidney transplant patients with positive crossmatch ...

9. Nephrology and Hypertension - Clinical trials

   Learn about clinical trials being conducted at Mayo Clinic to improve the diagnosis, care and outcomes for people with kidney conditions or hypertension.

10. T2 Lens Study - Mayo Clinic

    Significant renal dysfunction (eGFR < 45) or hepatic failure defined by elevated liver enzymes (AST above 36 U/L, ALT above 56 U/L). Participants with end ...